A glycolytic metabolite bypasses “two-hit” tumor suppression by BRCA2
Cell,
Cells carrying a monoallelic germline BRCA2 mutation can bypass Knudson’s “two-hit” requirement to initiate tumorigenesis when…
Cells carrying a monoallelic germline BRCA2 mutation can bypass Knudson’s “two-hit” requirement to initiate tumorigenesis when…
A greater number of breast cancers are genetically similar to rarer cases with faulty BRCA1 or BRCA2 genes, according to…
A type of drug that specifically targets BRCA breast cancers and has relatively few side effects may also benefit some people…